← Back to Discover
ADAR1 Capital Management, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $2,185,183,006
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $240,494,722
- PROTAGONIST THERAPEUTICS INC · COM · 74366E102 · shares: $117,782,587
- ROIVANT SCIENCES LTD · SHS · G76279101 · shares: $111,726,513
- STATE STR SPDR S&P 500 ETF T · TR UNIT · 78462F103 · shares: $96,398,299
- IMMUNOVANT INC · COM · 45258J102 · shares: $89,802,487
- ZAI LAB LTD · ADR · 98887Q104 · shares: $64,011,646
- AGIOS PHARMACEUTICALS INC · COM · 00847X104 · shares: $47,799,647
- CRINETICS PHARMACEUTICALS IN · COM · 22663K107 · shares: $45,730,234
- EA SERIES TRUST · ALPHA ARCH 1-3 · 02072L565 · shares: $39,473,966
- CYTOKINETICS INC · COM NEW · 23282W605 · shares: $39,009,097
Reported holdings
277 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 1,804,703 shares | $240,494,722 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 960,863 shares | $117,782,587 |
| ROIVANT SCIENCES LTD | SHS | G76279101 | — | 3,157,008 shares | $111,726,513 |
| STATE STR SPDR S&P 500 ETF T | TR UNIT | 78462F103 | — | 129,087 shares | $96,398,299 |
| IMMUNOVANT INC | COM | 45258J102 | — | 2,330,716 shares | $89,802,487 |
| ZAI LAB LTD | ADR | 98887Q104 | — | 3,369,034 shares | $64,011,646 |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | — | 1,288,053 shares | $47,799,647 |
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | — | 1,222,080 shares | $45,730,234 |
| EA SERIES TRUST | ALPHA ARCH 1-3 | 02072L565 | — | 337,125 shares | $39,473,966 |
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 457,907 shares | $39,009,097 |
| SEPTERNA INC | COM | 81734D104 | — | 940,747 shares | $31,505,617 |
| ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | — | 3,145,096 shares | $30,979,196 |
| EDITAS MEDICINE INC | COM | 28106W103 | — | 8,889,000 shares | $28,800,360 |
| DENALI THERAPEUTICS INC | COM | 24823R105 | — | 1,029,080 shares | $26,467,938 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 283,982 shares | $25,211,922 |
| VIR BIOTECHNOLOGY INC | COM | 92764N102 | — | 2,456,677 shares | $25,033,539 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 74,253 shares | $24,859,162 |
| INSMED INC | COM PAR $.01 | 457669307 | — | 228,520 shares | $24,364,802 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 619,542 shares | $23,053,158 |
| VIKING THERAPEUTICS INC | COM | 92686J106 | — | 574,038 shares | $22,393,222 |
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | — | 3,040,466 shares | $20,705,573 |
| MONOPAR THERAPEUTICS INC | COM NEW | 61023L207 | — | 217,595 shares | $20,147,121 |
| OVID THERAPEUTICS INC | COM | 690469101 | — | 7,417,479 shares | $19,953,019 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 387,718 shares | $19,676,689 |
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | — | 1,344,510 shares | $19,602,956 |
| ISHARES TR | RUSSELL 2000 ETF | 464287655 | PUT | 62,500 shares | $18,778,125 |
| STATE STR SPDR S&P 500 ETF T | TR UNIT | 78462F103 | PUT | 25,000 shares | $18,669,250 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 244,184 shares | $17,046,485 |
| INSPIRE MED SYS INC | COM | 457730109 | — | 374,617 shares | $16,711,664 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 87,509 shares | $16,388,686 |
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | — | 185,619 shares | $15,927,966 |
| PROTHENA CORP PLC | SHS | G72800108 | — | 1,554,535 shares | $15,218,898 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 136,158 shares | $15,117,623 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | — | 7,387,205 shares | $14,996,026 |
| UNIQURE NV | SHS | N90064101 | — | 324,672 shares | $14,954,392 |
| RALLYBIO CORP | COM | 75120L209 | — | 926,352 shares | $14,821,632 |
| REGENERON PHARMACEUTICALS | COM | 75886F107 | — | 22,208 shares | $13,847,576 |
| INVENTIVA SA | ADS | 46124U107 | — | 3,606,656 shares | $13,633,160 |
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | — | 404,014 shares | $13,413,265 |
| IONIS PHARMACEUTICALS INC | COM | 462222100 | — | 166,286 shares | $13,184,817 |
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 176,689 shares | $13,159,797 |
| SAREPTA THERAPEUTICS INC | COM | 803607100 | — | 730,649 shares | $13,129,763 |
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | — | 3,365,118 shares | $12,619,193 |
| VOR BIOPHARMA INC | COM NEW | 929033207 | — | 680,626 shares | $12,530,325 |
| SPDR SERIES TRUST | ST STR BLO 1 ETF | 78468R663 | — | 135,585 shares | $12,425,009 |
| EQUILLIUM INC | COM | 29446K106 | — | 3,758,569 shares | $12,027,421 |
| ADLAI NORTYE LTD | SPONSORED ADS | 00704R109 | — | 1,017,805 shares | $11,704,758 |
| CLIMB BIO INC | COM | 28658R106 | — | 822,649 shares | $10,727,343 |
| SPDR SERIES TRUST | ST STR SP BIOT | 78464A870 | PUT | 67,400 shares | $10,666,050 |
| HELIX ACQUISITION CORP III | USD CL A ORD SHS | G4444S107 | — | 1,000,000 shares | $10,600,000 |
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | — | 1,759,295 shares | $10,379,841 |
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | — | 2,238,684 shares | $10,208,399 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 339,276 shares | $10,123,996 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 166,550 shares | $10,052,958 |
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | — | 277,848 shares | $9,413,490 |
| UROGEN PHARMA LTD | COM | M96088105 | — | 252,395 shares | $9,288,136 |
| FAETH THERAPEUTICS INC | COM NEW | 81728A207 | — | 361,010 shares | $9,025,250 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | — | 494,378 shares | $8,879,029 |
| DBV TECHNOLOGIES S A | SPONSORED ADS | 23306J309 | — | 528,295 shares | $8,664,038 |
| SAVARA INC | COM | 805111101 | — | 1,403,409 shares | $8,644,999 |
| VAXCYTE INC | COM | 92243G108 | — | 146,034 shares | $8,488,956 |
| CG ONCOLOGY INC | COM | 156944100 | — | 118,664 shares | $8,431,077 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 298,886 shares | $8,063,944 |
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | — | 28,604 shares | $7,629,259 |
| AMANAT ACQUISITION CORP | CL A ORD | G0375M101 | — | 750,000 shares | $7,620,000 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 313,236 shares | $7,599,105 |
| BIOHAVEN LTD | COM | G1110E107 | — | 501,687 shares | $7,465,103 |
| PRIME MEDICINE INC | COM | 74168J101 | — | 1,997,552 shares | $7,370,967 |
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | — | 674,695 shares | $7,340,682 |
| OPUS GENETICS INC | COM | 67577R102 | — | 1,783,781 shares | $7,331,340 |
| LEXEO THERAPEUTICS INC | COM | 52886X107 | — | 1,565,950 shares | $7,289,497 |
| DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | — | 280,000 shares | $7,282,800 |
| REPLIMUNE GROUP INC | COM | 76029N106 | — | 655,784 shares | $7,259,529 |
| LEONABIO INC | COM | 04746L203 | — | 777,100 shares | $7,141,549 |
| KORRO BIO INC | COM | 500946108 | — | 540,054 shares | $7,117,912 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | G75226103 | — | 650,000 shares | $6,955,000 |
| INFLARX NV | COM | N44821101 | — | 3,000,000 shares | $6,720,000 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 358,333 shares | $6,704,410 |
| JANUX THERAPEUTICS INC | COM | 47103J105 | — | 420,881 shares | $6,464,732 |
| PLIANT THERAPEUTICS INC | COM | 729139105 | — | 5,509,724 shares | $6,281,085 |
| WHITEHAWK THERAPEUTICS INC | COM | 00032Q104 | — | 1,341,394 shares | $6,143,585 |
| KRYSTAL BIOTECH INC | COM | 501147102 | — | 16,420 shares | $6,102,821 |
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | — | 1,268,147 shares | $6,087,106 |
| PFIZER INC | COM | 717081103 | — | 252,400 shares | $6,077,792 |
| BRIGHTHOUSE FINL INC | COM | 10922N103 | — | 95,523 shares | $6,046,606 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | CALL | 44,400 shares | $5,916,744 |
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | — | 143,199 shares | $5,818,175 |
| ALECTOR INC | COM | 014442107 | — | 2,883,583 shares | $5,796,002 |
| FULCRUM THERAPEUTICS INC | COM | 359616109 | — | 1,565,029 shares | $5,728,006 |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | — | 69,800 shares | $5,689,398 |
| ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | — | 2,111,334 shares | $5,637,262 |
| OAKTREE ACQUISITION CORP III | UNIT 10/04/2029 | G6717R120 | — | 516,482 shares | $5,598,665 |
| GLOBUS MED INC | CL A | 379577208 | — | 70,100 shares | $5,538,601 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 216,752 shares | $5,245,398 |
| DISCIPLINED GROWTH | UNIT 99/99/9999 | G2775W127 | — | 500,000 shares | $5,020,000 |
| BHAV ACQUISITION CORP | UNIT 03/18/2031 | G1R59W127 | — | 495,000 shares | $5,004,450 |
| BRIDGEBIO PHARMA INC | NOTE 1.750% 3/0 | 10806XAJ1 | — | 30,000 principal | $4,999,140 |
| BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | — | 45,000 principal | $4,941,630 |
| DANAHER CORP DEL | COM | 235851102 | — | 25,932 shares | $4,939,527 |
| BOUNDLESS BIO INC | COM | 10170A100 | — | 1,968,216 shares | $4,920,540 |